BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

OraPharma Incorporated

OraPharma, Inc., a specialty pharmaceutical company founded in 1996 with an initial focus on the emerging field of oral health care, discovers, develops and commercializes therapeutics for oral health. OraPharma's initial product, ArestinTM, represents a promising therapeutic advance for the adjunct treatment of periodontal disease. Arestin is the first locally administered time-released antibiotic encapsulated in microspheres that effectively kills the germs that cause periodontal disease or periodontitis, a disease that affects more than 50 million people in the U.S. The Company's other technological initiatives, include a compound for the treatment of oral mucositis, an agent for bone and tissue regeneration, a next-generation periodontal therapeutic and a dental trauma preparation.


Contact Details:
732 Louis Drive
Warminster
PA
18974
United States of America
Tel:215-956-2200
Fax:
Email:
WWW:

www.orapharma.com/




Loading...

Recent Publications by OraPharma Incorporated:

Periodontitis in cardiology--a clinical perspective.
The association between ischemic cardiovascular disease and infectious...
28th September, 2005
OraPharma, Inc, Warminster, J Int Acad Periodontol. 2005 Apr;7(2):49-54.
A post-marketing study of 2805 patients treated for periodontal disease with Arestin.
Recent studies have demonstrated the effectiveness of locally delivered...
12th April, 2005
OraPharma, Inc., 732 Louis Drive, Warminster, PA 18974, USA. J Int Acad Periodontol. 2004 Oct;6(4 Suppl):150-3.
Are cardiac transplant patients more likely to have periodontitis? A case record study.
In several large epidemiological studies chronic periodontitis has been...
16th April, 2003
OraPharma J Int Acad Periodontol. 2002 Jul;4(3):95-100.

OraPharma Incorporated Patents:

US Patent No.Title
6946118 Formulations for treating or preventing mucositis
6893665 Formulations for treating or preventing mucositis
6683067 Formulations for treating or preventing mucositis
6682348 Dispensing apparatus and cartridge

OraPharma Incorporated (OPHM) Financial information Links from Barchart

OPHM Quote from from Barchart.com
OPHM Chart from from Barchart.com
OPHM Profile from from Barchart.com
OPHM Opinion from from Barchart.com

View more OraPharma Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 181 times since April 2007, the link to the organisation's website has been followed 32 times

Recent Search Terms used to find this page: schein pharmaceuticals and OraPharma, Inc. | orapharma | orapharma competitor | OraPharma | OraPharma | orapharma.com | .

Search for more companies in Warminster

Search for more companies in PA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OraPharma Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.